share_log

Jörn Jörgensen Is The Founder of EuroEyes International Eye Clinic Limited (HKG:1846) And Just Spent HK$1.3m On Shares

Simply Wall St ·  Sep 18, 2022 20:30

Investors who take an interest in EuroEyes International Eye Clinic Limited (HKG:1846) should definitely note that the Founder, Jörn Jörgensen, recently paid HK$5.04 per share to buy HK$1.3m worth of the stock. Although the purchase is not a big one, by either a percentage standpoint or absolute value, it can be seen as a good sign.

Check out our latest analysis for EuroEyes International Eye Clinic

EuroEyes International Eye Clinic Insider Transactions Over The Last Year

Notably, that recent purchase by Founder Jörn Jörgensen was not the only time they bought EuroEyes International Eye Clinic shares this year. They previously made an even bigger purchase of HK$1.3m worth of shares at a price of HK$6.59 per share. That means that an insider was happy to buy shares at above the current price of HK$4.96. Their view may have changed since then, but at least it shows they felt optimistic at the time. In our view, the price an insider pays for shares is very important. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price.

EuroEyes International Eye Clinic insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

insider-trading-volumeSEHK:1846 Insider Trading Volume September 19th 2022

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Insider Ownership Of EuroEyes International Eye Clinic

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. EuroEyes International Eye Clinic insiders own about HK$927m worth of shares (which is 56% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

What Might The Insider Transactions At EuroEyes International Eye Clinic Tell Us?

It is good to see the recent insider purchase. And the longer term insider transactions also give us confidence. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about EuroEyes International Eye Clinic. Looks promising! Therefore, you should definitely take a look at this FREE report showing analyst forecasts for EuroEyes International Eye Clinic.

But note: EuroEyes International Eye Clinic may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment